These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lhommée E; Wojtecki L; Czernecki V; Witt K; Maier F; Tonder L; Timmermann L; Hälbig TD; Pineau F; Durif F; Witjas T; Pinsker M; Mehdorn M; Sixel-Döring F; Kupsch A; Krüger R; Elben S; Chabardès S; Thobois S; Brefel-Courbon C; Ory-Magne F; Regis JM; Maltête D; Sauvaget A; Rau J; Schnitzler A; Schüpbach M; Schade-Brittinger C; Deuschl G; Houeto JL; Krack P; Lancet Neurol; 2018 Mar; 17(3):223-231. PubMed ID: 29452685 [TBL] [Abstract][Full Text] [Related]
10. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease. Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220 [TBL] [Abstract][Full Text] [Related]
11. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease. Mondillon L; Mermillod M; Musca SC; Rieu I; Vidal T; Chambres P; Auxiette C; Dalens H; Marie Coulangeon L; Jalenques I; Lemaire JJ; Ulla M; Derost P; Marques A; Durif F Neuropsychologia; 2012 Oct; 50(12):2869-2879. PubMed ID: 22944002 [TBL] [Abstract][Full Text] [Related]
12. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up. Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS; J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534 [TBL] [Abstract][Full Text] [Related]
13. Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients. Brun L; Lefaucheur R; Fetter D; Derrey S; Borden A; Wallon D; Bourre B; Maltête D Clin Neurol Neurosurg; 2014 Dec; 127():93-6. PubMed ID: 25459250 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746 [TBL] [Abstract][Full Text] [Related]
15. Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up. Ortega-Cubero S; Clavero P; Irurzun C; Gonzalez-Redondo R; Guridi J; Obeso JA; Rodriguez-Oroz MC Parkinsonism Relat Disord; 2013 May; 19(5):543-7. PubMed ID: 23453890 [TBL] [Abstract][Full Text] [Related]
16. The heterogeneity of non-motor symptoms of Parkinson's disease. Zhang N; Liu W; Ye M; Cohen AD; Zhang Y Neurol Sci; 2015 Apr; 36(4):577-84. PubMed ID: 25376559 [TBL] [Abstract][Full Text] [Related]
17. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease. Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186 [TBL] [Abstract][Full Text] [Related]